Potency assay design for adjuvanted recombinant proteins as malaria vaccines

Vaccine

Volumn 24, Issue 20, 2006, Pages 4264-4270

  Giersing, Birgitte K ^a   Dubovsky, Filip ^a   Saul, Allan ^b   Denamur, Francoise ^c   Minor, Philip ^d   Meade, Bruce ^e  

^a PATH Malaria Vaccine Initiative   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c GSK   (Belgium)

^d NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^e Division of Bacterial Products   (United States)

Author keywords

Assay; Potency; Recombinant protein; Vaccine

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT PROTEIN;

BIOASSAY; BIOTECHNOLOGY; CLINICAL TRIAL; CONFERENCE PAPER; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG PURIFICATION; DRUG RESPONSE; GOVERNMENT REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MALARIA; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; BIOLOGICAL ASSAY; MALARIA VACCINES; RECOMBINANT PROTEINS;

EID: 33646483915     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.01.005     Document Type: Conference Paper

References (16)

1. Hodder A.N., Crewther P.E., Matthew M.L., Reid G.E., Moritz R.L., Simpson R.J., et al. The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem 271 46 (1996) 29446-29452
2. Darko C.A., Angov E., Collins W.E., Bergmann-Leitner E.S., Girouard A.S., Hitt S.L., et al. The clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites. Infect Immun 73 l (2005) 287-297
3. Dutta S., Haynes J.D., Barbosa A., Ware L.A., Snavely J.D., Moch J.K., et al. Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum. Infect Immun 73 4 (2005) 2116-2122
4. Bharara R., Singh S., Pattnaik P., Chitnis C.E., and Sharma A. Structural analogs of sialic acid interfere with the binding of erythrocyte binding antigen-175 to glycophorin A, an interaction crucial for erythrocyte invasion by Plasmodium falciparum. Mol Biochem Parasitol 138 l (2004) 123-129
5. Kennedy M.C., Wang J., Zhang Y., Miles A.P., Chitsaz F., Saul A., et al. In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response. Infect Immun 70 12 (2002) 6948-6960
6. Saul A., Lawrence G., Allworth A., Elliott S., Anderson K., Rzepczyk C., et al. A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant. Vaccine 23 23 (2005) 3076-3083
7. Moorthy V.S., Good M.F., and Hill A.V. Malaria vaccine developments. Lancet 10 (2004) 150-156 363(9403)
8. Xiao L., Rafi-Janajreh A., Patterson P., Zhou Z., and Lal A.A. Adjuvants and malaria vaccine development. Chem Immunol 80 (2002) 343-365
9. Arakawa T., Tsuboi T., Kishimoto A., Sattabongkot J., Suwanabun N., Rungruang T., et al. Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes. Vaccine 21 23 (2003) 3143-3148
10. Carvalho L.J., Oliveira S.G., Theisen M., Alves F.A., Andrade M.C., Zanini G.M., et al. Immunization of Saimiri sciureus monkeys with Plasmodium falciparum merozoite surface protein-3 and glutamate-rich protein suggests that protection is related to antibody levels. Scand J Immunol 59 4 (2004) 363-372
11. Pinder M., Reece W.H., Plebanski M., Akinwunmi P., Flanagan K.L., Lee E.A., et al. Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi-immune adults in The Gambia. Clin Exp Immunol 135 2 (2004) 286-293
12. Finney D.J. Statistical methodology in biological assay. 3rd ed. (1978), Charles Griffin and Company, London
13. Finney D.J. Probit analysis. 3rd ed. (1971), Cambridge University Press, London
14. Sokol R.R., and Rolf F.J. Biometry: the principles and practice of statistics in biological research. 3rd ed. (1995), W.H. Freeman and Company, New York
15. Gaines-Das R.E., and Tydeman M.S. Iterative weighted regression analysis of logit responses: a program for analysis of bioasssays and immunoassays. Comput Programs Biomed 15 1 (1982) 13-21
16. European Pharmacopoeia Commission. Statistical analysis of results of biological assays and tests. European Pharmacopoeia, 5th ed. Strasburg: Council of Europe, 475-504.